54gene, a genomics startup, is reportedly shutting down after raising $45 million in funding over four years. Founded in 2019, the company aimed to bridge the genetic research gap in Africa, where less than 3% of genetic material used in global pharmaceutical research originates. However, it has faced internal turmoil, including CEO changes and legal … Continue reading The Demise of 54gene: Impact on Healthcare Tech Investment in Africa